{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:27:54Z","timestamp":1788193674970,"version":"build-2803163510"},"reference-count":138,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shanghai Innovation Medical Device Application Demonstration Project 2023","award":["23SHS05200"],"award-info":[{"award-number":["23SHS05200"]}]},{"name":"Shanghai Innovation Medical Device Application Demonstration Project 2023","award":["3502Z20224ZD1093"],"award-info":[{"award-number":["3502Z20224ZD1093"]}]},{"name":"Medical and Health Guided Project of Xiamen","award":["23SHS05200"],"award-info":[{"award-number":["23SHS05200"]}]},{"name":"Medical and Health Guided Project of Xiamen","award":["3502Z20224ZD1093"],"award-info":[{"award-number":["3502Z20224ZD1093"]}]},{"name":"2022 Key Clinical Specialty Discipline Construction Program of Fujian","award":["23SHS05200"],"award-info":[{"award-number":["23SHS05200"]}]},{"name":"2022 Key Clinical Specialty Discipline Construction Program of Fujian","award":["3502Z20224ZD1093"],"award-info":[{"award-number":["3502Z20224ZD1093"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>(1) Background: Small ubiquitin-like modifiers (SUMOs) are pivotal in post-translational modifications, influencing various cellular processes, such as protein localization, stability, and genome integrity. (2) Methods: This review explores the SUMO family, including its isoforms and catalytic cycle, highlighting their significance in regulating key biological functions in thyroid cancer. We discuss the multifaceted roles of SUMOylation in DNA repair mechanisms, protein stability, and the modulation of receptor activities, particularly in the context of thyroid cancer. (3) Results: The aberrant SUMOylation machinery contributes to tumorigenesis through altered gene expression and immune evasion mechanisms. Furthermore, we examine the therapeutic potential of targeting SUMOylation pathways in thyroid cancer treatment, emphasizing the need for further research to develop effective SUMOylation inhibitors. (4) Conclusions: By understanding the intricate roles of SUMOylation in cancer biology, we can pave the way for innovative therapeutic strategies to improve outcomes for patients with advanced tumors.<\/jats:p>","DOI":"10.3390\/biomedicines12102408","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T08:53:11Z","timestamp":1729500791000},"page":"2408","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The SUMO Family: Mechanisms and Implications in Thyroid Cancer Pathogenesis and Therapy"],"prefix":"10.3390","volume":"12","author":[{"given":"Bahejuan","family":"Jiaerken","sequence":"first","affiliation":[{"name":"Department of Surgery (Thyroid & Breast), Zhongshan Hospital, Fudan University, Shanghai 200032, China"},{"name":"School of Basic Medical Sciences, Fudan University, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Surgery (Thyroid & Breast), Zhongshan Hospital, Fudan University, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Surgery (Thyroid & Breast), Zhongshan Hospital, Fudan University, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Surgery (Thyroid & Breast), Zhongshan Hospital, Fudan University, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4657-3109","authenticated-orcid":false,"given":"Qiao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Surgery (Thyroid & Breast), Zhongshan Hospital, Fudan University, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilong","family":"Ai","sequence":"additional","affiliation":[{"name":"Department of Surgery (Thyroid & Breast), Zhongshan Hospital, Fudan University, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","article-title":"Thyroid cancer","volume":"401","author":"Chen","year":"2023","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S2213-8587(21)00027-9","article-title":"Thyroid cancer incidence trends by histology in 25 countries: A population-based study","volume":"9","author":"Bray","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.2023.26348","article-title":"Thyroid Cancer: A Review","volume":"331","author":"Boucai","year":"2024","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/acs.chemrev.6b00737","article-title":"Ubiquitin-like Protein Conjugation: Structures, Chemistry, and Mechanism","volume":"118","author":"Cappadocia","year":"2018","journal-title":"Chem. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev-biochem-061909-093311","article-title":"Sumoylation: A regulatory protein modification in health and disease","volume":"82","author":"Flotho","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/nrm2293","article-title":"Concepts in sumoylation: A decade on","volume":"8","author":"Melchior","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molcel.2005.03.012","article-title":"SUMO: A history of modification","volume":"18","author":"Hay","year":"2005","journal-title":"Mol. Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/embor.2008.183","article-title":"Function and regulation of protein neddylation. \u2018Protein modifications: Beyond the usual suspects\u2019 review series","volume":"9","author":"Rabut","year":"2008","journal-title":"EMBO Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0092-8674(00)81862-0","article-title":"A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2","volume":"88","author":"Mahajan","year":"1997","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21775\/cimb.035.001","article-title":"Recent Highlights: Onco Viral Exploitation of the SUMO System","volume":"35","author":"Mattoscio","year":"2020","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1038\/s41467-022-32920-x","article-title":"Crosstalk between SUMOylation and ubiquitylation controls DNA end resection by maintaining MRE11 homeostasis on chromatin","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"973","DOI":"10.7150\/thno.79688","article-title":"Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer","volume":"13","author":"Zhang","year":"2023","journal-title":"Theranostics"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Luise, C., Merolla, F., Leone, V., Paladino, S., Sarnataro, D., Fusco, A., and Celetti, A. (2012). Identification of sumoylation sites in CCDC6, the first identified RET partner gene in papillary thyroid carcinoma, uncovers a mode of regulating CCDC6 function on CREB1 transcriptional activity. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0049298"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"114801","DOI":"10.18632\/oncotarget.21954","article-title":"Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancer","volume":"8","author":"Lorenzen","year":"2017","journal-title":"Oncotarget"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.4049\/jimmunol.157.10.4277","article-title":"Protection against Fas\/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin","volume":"157","author":"Okura","year":"1996","journal-title":"J. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"11349","DOI":"10.1074\/jbc.273.18.11349","article-title":"Characterization of a second member of the sentrin family of ubiquitin-like proteins","volume":"273","author":"Kamitani","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6252","DOI":"10.1074\/jbc.275.9.6252","article-title":"Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2\/3","volume":"275","author":"Saitoh","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_19","first-page":"1081","article-title":"The post-translational modification, SUMOylation, and cancer (Review)","volume":"52","author":"Han","year":"2018","journal-title":"Int. J. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1242\/jcs.038570","article-title":"Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3","volume":"121","author":"Evdokimov","year":"2008","journal-title":"J. Cell Sci."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Liang, Y.C., Lee, C.C., Yao, Y.L., Lai, C.C., Schmitz, M.L., and Yang, W.M. (2016). SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies. Sci. Rep., 6.","DOI":"10.1038\/srep26509"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/18457","article-title":"A new protease required for cell-cycle progression in yeast","volume":"398","author":"Li","year":"1999","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.str.2004.05.023","article-title":"A basis for SUMO protease specificity provided by analysis of human Senp2 and a Senp2-SUMO complex","volume":"12","author":"Reverter","year":"2004","journal-title":"Structure"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature01456","article-title":"Insights into the ubiquitin transfer cascade from the structure of the activating enzyme for NEDD8","volume":"422","author":"Walden","year":"2003","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/sj.emboj.7600552","article-title":"Structures of the SUMO E1 provide mechanistic insights into SUMO activation and E2 recruitment to E1","volume":"24","author":"Lois","year":"2005","journal-title":"EMBO J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrm2673","article-title":"Ubiquitin-like protein activation by E1 enzymes: The apex for downstream signalling pathways","volume":"10","author":"Schulman","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"26799","DOI":"10.1074\/jbc.272.43.26799","article-title":"Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p","volume":"272","author":"Johnson","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.molcel.2013.01.013","article-title":"Structure of a ubiquitin E1-E2 complex: Insights to E1-E2 thioester transfer","volume":"49","author":"Olsen","year":"2013","journal-title":"Mol. Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.molcel.2007.05.023","article-title":"The intrinsic affinity between E2 and the Cys domain of E1 in ubiquitin-like modifications","volume":"27","author":"Wang","year":"2007","journal-title":"Mol. Cell"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Wang, J., Taherbhoy, A.M., Hunt, H.W., Seyedin, S.N., Miller, D.W., Miller, D.J., Huang, D.T., and Schulman, B.A. (2010). Crystal structure of UBA2(ufd)-Ubc9: Insights into E1-E2 interactions in Sumo pathways. PLoS ONE, 5.","DOI":"10.2210\/pdb3onh\/pdb"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1042\/BCJ20190232","article-title":"Structural insights into SUMO E1-E2 interactions in Arabidopsis uncovers a distinctive platform for securing SUMO conjugation specificity across evolution","volume":"476","author":"Liu","year":"2019","journal-title":"Biochem. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.molcel.2017.01.008","article-title":"S. pombe Uba1-Ubc15 Structure Reveals a Novel Regulatory Mechanism of Ubiquitin E2 Activity","volume":"65","author":"Lv","year":"2017","journal-title":"Mol. Cell"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nsmb1104","article-title":"Lysine activation and functional analysis of E2-mediated conjugation in the SUMO pathway","volume":"13","author":"Yunus","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/bs.mie.2018.12.026","article-title":"Methods to study SUMO dynamics in yeast","volume":"618","author":"Pabst","year":"2019","journal-title":"Methods Enzymol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1515\/bmc-2016-0030","article-title":"SUMO conjugation\u2014A mechanistic view","volume":"8","author":"Pichler","year":"2017","journal-title":"Biomol. Concepts"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-biochem-060815-014922","article-title":"Ubiquitin Ligases: Structure, Function, and Regulation","volume":"86","author":"Zheng","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Tozluo\u011flu, M., Karaca, E., Nussinov, R., and Halilo\u011flu, T. (2010). A mechanistic view of the role of E3 in sumoylation. PLoS Comput. Biol., 6.","DOI":"10.1371\/journal.pcbi.1000913"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1042\/BST20190357","article-title":"Molecular mechanisms in SUMO conjugation","volume":"48","author":"Lascorz","year":"2020","journal-title":"Biochem. Soc. Trans."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrm3478","article-title":"Function and regulation of SUMO proteases","volume":"13","author":"Hickey","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Claessens, L.A., and Vertegaal, A.C.O. (2024). SUMO proteases: From cellular functions to disease. Trends Cell Biol.","DOI":"10.1016\/j.tcb.2024.01.002"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cell.2007.08.045","article-title":"SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia","volume":"131","author":"Cheng","year":"2007","journal-title":"Cell"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.molcel.2010.03.005","article-title":"SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development","volume":"38","author":"Kang","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41467-017-02413-3","article-title":"Desumoylase SENP6 maintains osteochondroprogenitor homeostasis by suppressing the p53 pathway","volume":"9","author":"Li","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/embor.2012.125","article-title":"Ubiquitin-specific protease-like 1 (USPL1) is a SUMO isopeptidase with essential, non-catalytic functions","volume":"13","author":"Schulz","year":"2012","journal-title":"EMBO Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/embor.2012.3","article-title":"DeSUMOylating isopeptidase: A second class of SUMO protease","volume":"13","author":"Shin","year":"2012","journal-title":"EMBO Rep."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Nayak, A., and Muller, S. (2014). SUMO-specific proteases\/isopeptidases: SENPs and beyond. Genome Biol., 15.","DOI":"10.1186\/s13059-014-0422-2"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"jcs211904","DOI":"10.1242\/jcs.211904","article-title":"SUMO-specific proteases and isopeptidases of the SENP family at a glance","volume":"131","author":"Kunz","year":"2018","journal-title":"J. Cell Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1242\/jcs.102889","article-title":"SUMOylation of HNF4alpha regulates protein stability and hepatocyte function","volume":"125","author":"Zhou","year":"2012","journal-title":"J. Cell Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/ng.3451","article-title":"TRAIP promotes DNA damage response during genome replication and is mutated in primordial dwarfism","volume":"48","author":"Harley","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.bbrc.2016.01.141","article-title":"SUMOylation regulates nuclear localization and stability of TRAIP\/RNF206","volume":"470","author":"Park","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/nar\/gkl1168","article-title":"Sumoylation delays the ATF7 transcription factor subcellular localization and inhibits its transcriptional activity","volume":"35","author":"Hamard","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cell.2011.11.062","article-title":"Fibroblast growth factor-21 regulates PPAR\u03b3 activity and the antidiabetic actions of thiazolidinediones","volume":"148","author":"Dutchak","year":"2012","journal-title":"Cell"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"82491","DOI":"10.18632\/oncotarget.19700","article-title":"PPAR\u03b3 sumoylation-mediated lipid accumulation in lung cancer","volume":"8","author":"Phan","year":"2017","journal-title":"Oncotarget"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1021\/mp700103m","article-title":"Xenoreceptors CAR and PXR activation and consequences on lipid metabolism, glucose homeostasis, and inflammatory response","volume":"5","author":"Moreau","year":"2008","journal-title":"Mol. Pharm."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.18632\/oncotarget.23269","article-title":"RAS GTPases are modified by SUMOylation","volume":"9","author":"Choi","year":"2018","journal-title":"Oncotarget"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"17574","DOI":"10.1074\/jbc.RA118.003723","article-title":"K-Ras Lys-42 is crucial for its signaling, cell migration, and invasion","volume":"293","author":"Choi","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1007\/s00018-020-03525-8","article-title":"What turns CREB on? And off? And why does it matter?","volume":"77","author":"Steven","year":"2020","journal-title":"Cell Mol. Life Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mrfmmm.2004.09.010","article-title":"Characterization of novel non-clonal intrachromosomal rearrangements between the H4 and PTEN genes (H4\/PTEN) in human thyroid cell lines and papillary thyroid cancer specimens","volume":"570","author":"Puxeddu","year":"2005","journal-title":"Mutat. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1038\/onc.2010.179","article-title":"CCDC6 represses CREB1 activity by recruiting histone deacetylase 1 and protein phosphatase 1","volume":"29","author":"Leone","year":"2010","journal-title":"Oncogene"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/sj.onc.1206981","article-title":"H4(D10S170), a gene frequently rearranged with RET in papillary thyroid carcinomas: Functional characterization","volume":"23","author":"Celetti","year":"2004","journal-title":"Oncogene"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.1038\/sj.onc.1210446","article-title":"Involvement of H4(D10S170) protein in ATM-dependent response to DNA damage","volume":"26","author":"Merolla","year":"2007","journal-title":"Oncogene"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s43018-023-00525-y","article-title":"Age-associated microenvironmental changes highlight the role of PDGF-C in ER(+) breast cancer metastatic relapse","volume":"4","author":"Turrell","year":"2023","journal-title":"Nat. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1042\/BJ20111020","article-title":"Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: Implications for breast cancer progression","volume":"441","author":"Hurst","year":"2012","journal-title":"Biochem. J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1111\/j.1742-4658.2005.04989.x","article-title":"Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family","volume":"272","author":"Reigstad","year":"2005","journal-title":"Febs J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.yexcr.2005.11.035","article-title":"Nuclear localisation of endogenous SUMO-1-modified PDGF-C in human thyroid tissue and cell lines","volume":"312","author":"Reigstad","year":"2006","journal-title":"Exp. Cell Res."},{"key":"ref_66","first-page":"655","article-title":"Papillary thyroid cancer is characterized by altered expression of genes involved in the sumoylation process","volume":"29","author":"Tuccilli","year":"2015","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1158\/0008-5472.CAN-16-2958","article-title":"The Role of PIAS SUMO E3-Ligases in Cancer","volume":"77","author":"Rabellino","year":"2017","journal-title":"Cancer Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1038\/s41467-024-47751-1","article-title":"dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe","volume":"15","author":"Rodrigues","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/0284186X.2012.741326","article-title":"Health-related quality of life and disease specific symptoms in long-term thyroid cancer survivors: A study from the population-based PROFILES registry","volume":"52","author":"Husson","year":"2013","journal-title":"Acta Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S2213-8587(20)30401-0","article-title":"Global patterns and trends in incidence and mortality of thyroid cancer in children and adolescents: A population-based study","volume":"9","author":"Vaccarella","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1210\/jc.2008-0660","article-title":"Clinical and economic outcomes of thyroid and parathyroid surgery in children","volume":"93","author":"Sosa","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/CIRCRESAHA.123.323398","article-title":"SUMOylation Fine-Tunes Endothelial HEY1 in the Regulation of Angiogenesis","volume":"134","author":"Ren","year":"2024","journal-title":"Circ. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3892\/ijo.2020.5097","article-title":"Dexamethasone inhibits stemness maintenance and enhances chemosensitivity of hepatocellular carcinoma stem cells by inducing deSUMOylation of HIF-1\u03b1 and Oct4","volume":"57","author":"Jiang","year":"2020","journal-title":"Int. J. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Liu, D., Li, Z., Yang, Z., Ma, J., and Mai, S. (2021). Ginkgoic acid impedes gastric cancer cell proliferation, migration and EMT through inhibiting the SUMOylation of IGF-1R. Chem. Biol. Interact., 337.","DOI":"10.1016\/j.cbi.2021.109394"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12964-024-01573-2","article-title":"SUMOylation of annexin A6 retards cell migration and tumor growth by suppressing RHOU\/AKT1-involved EMT in hepatocellular carcinoma","volume":"22","author":"Yang","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1158\/0008-5472.CAN-22-4017","article-title":"SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer","volume":"83","author":"Wei","year":"2023","journal-title":"Cancer Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1002\/mco2.123","article-title":"SENP3-mediated TIP60 deSUMOylation is required for DNA-PKcs activity and DNA damage repair","volume":"3","author":"Han","year":"2022","journal-title":"MedComm"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00412-013-0408-y","article-title":"Multiple crosstalks between mRNA biogenesis and SUMO","volume":"122","author":"Geoffroy","year":"2013","journal-title":"Chromosoma"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"7734","DOI":"10.1093\/nar\/gkz634","article-title":"DAXX in cancer: Phenomena, processes, mechanisms and regulation","volume":"47","author":"Mahmud","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.humpath.2013.01.022","article-title":"Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence","volume":"44","author":"Tsourlakis","year":"2013","journal-title":"Hum. Pathol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"13620","DOI":"10.1074\/jbc.M112.446369","article-title":"Death domain-associated protein DAXX promotes ovarian cancer development and chemoresistance","volume":"288","author":"Pan","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/cam4.1144","article-title":"Prognostic significance of Daxx NCR (Nuclear\/Cytoplasmic Ratio) in gastric cancer","volume":"6","author":"Xu","year":"2017","journal-title":"Cancer Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0006-291X(02)00699-X","article-title":"Modification of Daxx by small ubiquitin-related modifier-1","volume":"295","author":"Jang","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41422-018-0023-9","article-title":"SUMO suppresses and MYC amplifies transcription globally by regulating CDK9 sumoylation","volume":"28","author":"Yu","year":"2018","journal-title":"Cell Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.cels.2018.03.003","article-title":"Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas","volume":"6","author":"Schaub","year":"2018","journal-title":"Cell Syst."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/j.semcancer.2015.03.004","article-title":"Immune evasion in cancer: Mechanistic basis and therapeutic strategies","volume":"35","author":"Vinay","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e155224","DOI":"10.1172\/JCI155224","article-title":"SENP7 senses oxidative stress to sustain metabolic fitness and antitumor functions of CD8+ T cells","volume":"132","author":"Wu","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1038\/s41467-018-05676-6","article-title":"SENP3 maintains the stability and function of regulatory T cells via BACH2 deSUMOylation","volume":"9","author":"Yu","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e152383","DOI":"10.1172\/JCI152383","article-title":"Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer","volume":"132","author":"Demel","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.7150\/thno.54967","article-title":"The crosstalk between m(6)A RNA methylation and other epigenetic regulators: A novel perspective in epigenetic remodeling","volume":"11","author":"Zhao","year":"2021","journal-title":"Theranostics"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","article-title":"Metabolic reprogramming and epigenetic modifications on the path to cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Protein Cell"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Zhu, S., Gu, H., Peng, C., Xia, F., Cao, H., and Cui, H. (2022). Regulation of Glucose, Fatty Acid and Amino Acid Metabolism by Ubiquitination and SUMOylation for Cancer Progression. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.849625"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Zhou, Q., Yin, Y., Yu, M., Gao, D., Sun, J., Yang, Z., Weng, J., Chen, W., Atyah, M., and Shen, Y. (2022). GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism. Redox Biol., 56.","DOI":"10.1016\/j.redox.2022.102458"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/s41467-021-22163-7","article-title":"SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis","volume":"12","author":"Shangguan","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e34010","DOI":"10.1016\/j.heliyon.2024.e34010","article-title":"SENP2 promotes ESCC proliferation through SETDB1 deSUMOylation and enhanced fatty acid metabolism","volume":"10","author":"Sun","year":"2024","journal-title":"Heliyon"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40164-023-00420-3","article-title":"The emerging roles of SUMOylation in the tumor microenvironment and therapeutic implications","volume":"12","author":"Gu","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pharmrev.120.000053","article-title":"E1 Enzymes as Therapeutic Targets in Cancer","volume":"73","author":"Barghout","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/ni.3342","article-title":"Sumoylation coordinates the repression of inflammatory and anti-viral gene-expression programs during innate sensing","volume":"17","author":"Decque","year":"2016","journal-title":"Nat. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1084\/jem.20101159","article-title":"Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells","volume":"208","author":"Fuertes","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2009.05.006","article-title":"A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene","volume":"137","author":"Luo","year":"2009","journal-title":"Cell"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1093\/nar\/gky484","article-title":"Regulation of miR-34b\/c-targeted gene expression program by SUMOylation","volume":"46","author":"Li","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"12326","DOI":"10.1038\/ncomms12326","article-title":"Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal","volume":"7","author":"Du","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.molcel.2009.12.024","article-title":"Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: The NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ","volume":"37","author":"Brownell","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nature07884","article-title":"An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer","volume":"458","author":"Soucy","year":"2009","journal-title":"Nature"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/nchembio.2463","article-title":"Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor","volume":"13","author":"He","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1136\/gutjnl-2018-317856","article-title":"SUMO pathway inhibition targets an aggressive pancreatic cancer subtype","volume":"69","author":"Hassan","year":"2020","journal-title":"Gut"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1021\/acsmedchemlett.0c00353","article-title":"Synthesis and Evaluation of Ginkgolic Acid Derivatives as SUMOylation Inhibitors","volume":"11","author":"Brackett","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.omto.2019.12.005","article-title":"Ginkgolic Acid, a SUMO-1 Inhibitor, Inhibits the Progression of Oral Squamous Cell Carcinoma by Alleviating SUMOylation of SMAD4","volume":"16","author":"Liu","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ja.2013.142","article-title":"Inhibition of protein SUMOylation by davidiin, an ellagitannin from Davidia involucrata","volume":"67","author":"Takemoto","year":"2014","journal-title":"J. Antibiot."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e09003","DOI":"10.7554\/eLife.09003","article-title":"A gene-expression screen identifies a non-toxic sumoylation inhibitor that mimics SUMO-less human LRH-1 in liver","volume":"4","author":"Suzawa","year":"2015","journal-title":"Elife"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ja.2009.10","article-title":"Kerriamycin B inhibits protein SUMOylation","volume":"62","author":"Fukuda","year":"2009","journal-title":"J. Antibiot."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1038\/s41467-018-07015-1","article-title":"Molecular mechanism of a covalent allosteric inhibitor of SUMO E1 activating enzyme","volume":"9","author":"Lv","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"eaba7791","DOI":"10.1126\/scitranslmed.aba7791","article-title":"A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models","volume":"13","author":"Lightcap","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1136\/gutjnl-2021-324834","article-title":"Targeting pancreatic cancer by TAK-981: A SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model","volume":"71","author":"Kumar","year":"2022","journal-title":"Gut"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1182\/blood.2021014267","article-title":"The SUMOylation inhibitor subasumstat potentiates rituximab activity by IFN1-dependent macrophage and NK cell stimulation","volume":"139","author":"Nakamura","year":"2022","journal-title":"Blood"},{"key":"ref_116","first-page":"98","article-title":"SUMOylation inhibitor TAK-981 (subasumstat) synergizes with 5-azacytidine in preclinical models of acute myeloid leukemia","volume":"109","author":"Gabellier","year":"2024","journal-title":"Haematologica"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.trecan.2020.11.009","article-title":"Targeting SUMO Signaling to Wrestle Cancer","volume":"7","author":"Kroonen","year":"2021","journal-title":"Trends Cancer"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Liu, J., Li, X., Chen, J., Guo, J., Guo, H., Zhang, X., Fan, J., Zhang, K., Mao, J., and Zhou, B. (2024). Targeting SUMOylation with an injectable nanocomposite hydrogel to optimize radiofrequency ablation therapy for hepatocellular carcinoma. J. Nanobiotechnology, 22.","DOI":"10.1186\/s12951-024-02579-1"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Brand, M., Bommeli, E.B., Rutimann, M., Lindenmann, U., and Riedl, R. (2022). Discovery of a Dual SENP1 and SENP2 Inhibitor. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232012085"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1080\/13880209.2016.1214742","article-title":"Anti-hepatocellular carcinoma activity and mechanism of chemopreventive compounds: Ursolic acid derivatives","volume":"54","author":"Huang","year":"2016","journal-title":"Pharm. Biol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1080\/07391102.2021.1880480","article-title":"Identification of novel anti-cancer agents, applying in silico method for SENP1 protease inhibition","volume":"40","author":"Taghvaei","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"e004037","DOI":"10.1136\/jitc-2021-004037","article-title":"Gallic acid induces T-helper-1-like T(reg) cells and strengthens immune checkpoint blockade efficacy","volume":"10","author":"Deng","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"120122","DOI":"10.1016\/j.lfs.2021.120122","article-title":"Computational drug repurposing of bethanidine for SENP1 inhibition in cardiovascular diseases treatment","volume":"292","author":"Taghvaei","year":"2022","journal-title":"Life Sci."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Huang, W., He, T., Chai, C., Yang, Y., Zheng, Y., Zhou, P., Qiao, X., Zhang, B., Liu, Z., and Wang, J. (2012). Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0037693"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"58995","DOI":"10.18632\/oncotarget.10636","article-title":"Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.chembiol.2009.01.009","article-title":"Ginkgolic acid inhibits protein SUMOylation by blocking formation of the E1-SUMO intermediate","volume":"16","author":"Fukuda","year":"2009","journal-title":"Chem. Biol."},{"key":"ref_127","unstructured":"Chen, Y., and Li, Y.J. (2012). Bicyclic and Tricyclic Inhibitors of Sumoylation Enzymes and Methods of Their Use. (PTC\/US2011\/060063), W.O. Patent."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1182\/bloodadvances.2022007875","article-title":"SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma","volume":"7","author":"Heynen","year":"2023","journal-title":"Blood Adv."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/10409238.2018.1488803","article-title":"SLX4: Multitasking to maintain genome stability","volume":"53","author":"Guervilly","year":"2018","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1101\/gad.321125.118","article-title":"The deSUMOylase SENP2 coordinates homologous recombination and nonhomologous end joining by independent mechanisms","volume":"33","author":"Garvin","year":"2019","journal-title":"Genes. Dev."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1038\/onc.2012.250","article-title":"SUMO-specific protease 1 promotes prostate cancer progression and metastasis","volume":"32","author":"Wang","year":"2013","journal-title":"Oncogene"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/cas.12626","article-title":"Tumor-suppressive microRNA-145 induces growth arrest by targeting SENP1 in human prostate cancer cells","volume":"106","author":"Wang","year":"2015","journal-title":"Cancer Sci."},{"key":"ref_133","first-page":"196","article-title":"Inhibition of SENP6-induced radiosensitization of human hepatocellular carcinoma cells by blocking radiation-induced NF-\u03baB activation","volume":"28","author":"Qian","year":"2013","journal-title":"Cancer Biother. Radiopharm."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.1016\/j.bmcl.2012.06.084","article-title":"Discovery of 1-[4-(N-benzylamino)phenyl]-3-phenylurea derivatives as non-peptidic selective SUMO-sentrin specific protease (SENP)1 inhibitors","volume":"22","author":"Uno","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejmech.2016.06.018","article-title":"Identification of SENP1 inhibitors through in silico screening and rational drug design","volume":"122","author":"Zhao","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12935-024-03323-3","article-title":"Identification of SUMOylation-related biomarkers in papillary thyroid carcinoma","volume":"24","author":"Li","year":"2024","journal-title":"Cancer Cell Int."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Chen, Z., Yang, J., Tang, L., Sun, X., Li, Y., Sheng, Z., Ding, H., Xu, C., Tong, X., and Zhao, J. (2023). SUMOylation patterns and signature characterize the tumor microenvironment and predict prognosis in lung adenocarcinoma. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1094588"},{"key":"ref_138","unstructured":"Wu, Q., Liu, W., Zheng, J.J., Wang, C., and Ai, Z.L. (2024). Correlationship between total proteins SUMOylation and papillary thyroid carcinoma in males. J. Surg. Concepts Pract., in press."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/12\/10\/2408\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:17:25Z","timestamp":1760113045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/12\/10\/2408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":138,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["biomedicines12102408"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines12102408","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,21]]}}}